Aclarion (NASDAQ:ACON – Get Free Report) is projected to issue its quarterly earnings data before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($50.00) per share and revenue of $0.02 million for the quarter.
Aclarion Stock Down 3.0 %
ACON opened at $0.75 on Wednesday. The company has a fifty day moving average of $2.89 and a 200 day moving average of $36.44. Aclarion has a fifty-two week low of $0.61 and a fifty-two week high of $231.15.
Analyst Upgrades and Downgrades
Several analysts have recently issued reports on ACON shares. Maxim Group reaffirmed a “hold” rating on shares of Aclarion in a report on Friday, December 13th. Ascendiant Capital Markets decreased their price objective on shares of Aclarion from $502.50 to $435.50 and set a “buy” rating for the company in a research note on Wednesday, November 27th.
About Aclarion
Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.
Featured Stories
- Five stocks we like better than Aclarion
- Health Care Stocks Explained: Why You Might Want to Invest
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- NVIDIA Insiders Sell: This Is What It Means for the Market
- 3 Healthcare Dividend Stocks to Buy
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Aclarion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclarion and related companies with MarketBeat.com's FREE daily email newsletter.
